MEETINGS ON THE ADIPOSE CELL & INSULIN ACTION SECRETION
MEETINGS ON THE ADIPOSE CELL & INSULIN ACTION SECRETION
批准号:
2017862
负责人:
IRA D. GOLDFINE
金额:
$2.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-31 至 1997-12-31
中文摘要
在糖尿病和脂肪领域取得了重要进展
最近几年的细胞研究,就这些主题举行会议
非常及时。这些同时举行的会议将是多学科的,
将来自学术界和产业界的调查人员聚集在一起
细胞生物学、分子生物学、免疫学和生物化学
内分泌学和新陈代谢的临床学科。素数
目标是提出新的发现,以刺激交叉
共享基础和临床研究人员的受精情况
人类对激素分泌和信号转导及机制的兴趣
疾病。糖尿病是一种疾病,特点是
高血糖,损害β细胞胰岛素的未知分子缺陷
分泌和外周胰岛素反应性。在以下方面取得了显著进展
细胞和分子生物学研究揭示了一些相关的
II型糖尿病关键过程的组成和机制
综合症。共同的细胞信号元件,控制疾病和
胰岛素在肝脏、肌肉和脂肪中的作用包括:酪氨酸激酶;GTP-
结合蛋白,如ras和蛋白丝氨酸/苏氨酸激酶
瀑布。控制胰岛β细胞的胰岛素分泌涉及许多
这些相同的组件。脂肪细胞及其亲本脂肪组织
代表独特的实验系统,在其中理解
参与调控的各种信号通路的整合
差异化和发展性。脂肪细胞对一种
非常广泛的荷尔蒙引起了大量的井水
特征性反应,包括细胞/组织生长和发育,
底物运输、脂肪生成、脂肪分解和蛋白质运输
和分泌物。细胞内的许多特征
胰岛素信号系统及其在糖尿病中的破坏作用已被研究
在脂肪细胞中,由于细胞的胰岛素反应性
以及从患者和患者那里轻松地获得培养它们
实验动物。最近的进展突显了这一积极作用
脂肪组织也在糖尿病的代谢改变中发挥作用。
高血糖和高胰岛素血症对细胞胰岛素的影响
在脂肪细胞中的作用。分子机制涉及多种不同的
信号通路包括G蛋白调节的效应系统,如
作为腺酰环化酶和磷脂酶,受体相关和
胞浆酪氨酸激酶和磷酸酶。因为有重要的
糖尿病和肥胖症之间的关系;以及2)信号
参与免疫细胞反应、胰岛素分泌和
行动和脂肪细胞调控,这次会议应该提供一个
为基础和临床研究人员提供独特的科学形式
在激素作用和分泌的研究中。
英文摘要
Important advances have been made in the areas of diabetes and adipose
cell research in recent years, making conferences on these topics
extremely timely. These concurrent meetings will be multidisciplinary,
bringing together investigators from academia and industry representing
cell biology, molecular biology, immunology and biochemistry, and the
clinical disciplines of endocrinology and metabolism. The prime
objective is to present new findings that will stimulate cross-
fertilization among basic and clinical investigators sharing common
interests in hormone secretion and signaling and mechanisms of human
diseases. Diabetes mellitus is a disease characterized by
hyperglycemia, unknown molecular defects that impair beta cell insulin
secretion and peripheral insulin responsiveness. Dramatic progress in
cell and molecular biology research has revealed a number of related
components and mechanisms underlying key processes in Type II diabetes
syndromes. Common cellular signaling elements that control disease and
insulin action in liver, muscle and fat include: tyrosine kinases; GTP-
binding proteins such as ras; and protein serine/threonine kinase
cascades. Control of insulin secretion in beta cells involves many of
these same components. The adipose cell and its parent adipose tissue
represent unique experimental systems in which to understand the
integration of various signaling pathways involved in the regulation
of differentiation and development. Adipose cells are responsive to a
remarkably wide range of hormones which elicit a host of well
characterized responses, including cell/tissue growth and development,
substrate transport, lipogenesis, lipolysis, and protein trafficking
and secretion. Much of the characterization of the intracellular
insulin signaling system and its disruption in diabetes has been worked
out in adipose cells, due to the insulin responsiveness of the cells
and the ease of obtaining an culturing them from both patients and
experimental animals. Recent advances have highlighted the active role
the adipose tissue plays in the altered metabolism of diabetes as well
as the impact of hyperglycemia and hyperinsulinemia on cellular insulin
action in the fat cell. Molecular mechanisms involved in various
signaling pathways include G-protein regulated effector systems such
as adenylyl cyclase and phospholipases, receptor-associated and
cytosolic tyrosine kinases and phosphatases. Since there are important
relationships between: 1) diabetes and obesity; and 2) signaling
pathways involved in immune cell responses, insulin secretion and
action, and adipose cell regulation, this meeting should provide a
unique scientific form for basic and clinical investigators involved
in studies of hormone action and secretion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipoic Acid and Insulin Resistance
-
批准号:7254576
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2007
-
负责人:IRA D. GOLDFINE
-
依托单位:
Lipoic Acid and Insulin Resistance
-
批准号:7462326
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2007
-
负责人:IRA D. GOLDFINE
-
依托单位:
Lipoic Acid and Insulin Resistance
-
批准号:7623464
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2007
-
负责人:IRA D. GOLDFINE
-
依托单位:
MECHANISMS OF INSULIN RESISTANCE IN LEAN NONDIABETICS
-
批准号:7204905
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2005
-
负责人:IRA D. GOLDFINE
-
依托单位:
MECHANISMS OF INSULIN RESISTANCE IN LEAN NONDIABETICS
-
批准号:7202645
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2005
-
负责人:IRA D. GOLDFINE
-
依托单位:
Mechanisms of Insulin Resistance in Lean Nondiabetics
-
批准号:6972305
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2004
-
负责人:IRA D. GOLDFINE
-
依托单位:
Exercise Training in Insulin Resistant Non-Diabetics
-
批准号:6617386
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2003
-
负责人:IRA D. GOLDFINE
-
依托单位:
Exercise Training in Insulin Resistant Non-Diabetics
-
批准号:6729959
-
项目类别:
-
资助金额:$33.67万
-
财政年份:2003
-
负责人:IRA D. GOLDFINE
-
依托单位:
Exercise Training in Insulin Resistant Non-Diabetics
-
批准号:7024498
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2003
-
负责人:IRA D. GOLDFINE
-
依托单位:
Exercise Training in Insulin Resistant Non-Diabetics
-
批准号:6863622
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2003
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 and Insulin Receptor Signaling
-
批准号:6517697
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 and Insulin Receptor Signaling
-
批准号:7046519
-
项目类别:
-
资助金额:$3.32万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 and Insulin Receptor Signaling
-
批准号:7250935
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 Insulin Receptor Signaling
-
批准号:7619515
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 and Insulin Receptor Signaling
-
批准号:6635221
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 and Insulin Receptor Signaling
-
批准号:6725368
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 and Insulin Receptor Signaling
-
批准号:6328242
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 and Insulin Receptor Signaling
-
批准号:7414871
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC-1 Insulin Receptor Signaling
-
批准号:7141952
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2001
-
负责人:IRA D. GOLDFINE
-
依托单位:
PC1 IN INSULIN RESISTANT HUMANS
-
批准号:2906088
-
项目类别:
-
资助金额:$19.88万
-
财政年份:1997
-
负责人:IRA D. GOLDFINE
-
依托单位:
海外基金